High potency FMD vaccines targeted to control emergencies and develop eradication programs, customized according to market needs: mono, bi, tri, or tetravalent.
- High antigen mass (antigen payload)
- Early inmune response and high potency
- Long duration of immunity
- Highly purified antigens that provide safety
- Absence of NSP allow to differenciate vaccinated from naturally infected animals (DIVA vaccines)
- Long shelf life with high stability (at least 24 months at 2º C to 8º C)